Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

van der Wal SEI.

46 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Receptor Pharmacology 21 Depression 17 Mechanism of Action 14 Emotional Processing 12 Brain Imaging 11 Aging 9 Clinical Trial 9 Safety 9 Toxicity 8 Chronic Pain 8 Addiction 8 Pharmacology 7

Journals

Biological Psychiatry 4 Frontiers in psychiatry 3 European Neuropsychopharmacology 3 Psychopharmacology 2 The Mouseion at the JAXlibrary (Jackson Laboratory) 2 Journal of Psychopharmacology 1 Frontiers in Public Health 1 Psychedelic Medicine 1

Publication history

Blocking 5-HT2B receptors abolishes psilocybin’s efficacy in the rat forced swim testJournal of Psychopharmacology · 2026-06-22 Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New MexicoFrontiers in Public Health · 2026-06-16 Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.Frontiers in psychiatry · 2025-12-31 Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic ResearchPsychedelic Medicine · 2025-12-18 Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational StudyResearch Square · 2025-12-09 Engineering artificial biosynthetic pathways for efficient microbial production of psilocybin and psilocinMetabolic Engineering · 2025-11-04 Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.Unknown journal · 2025-09-22 Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysisTranslational Psychiatry · 2025-08-28 Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of N,N-Dimethyltryptamine and Harmine in a Meditation RetreatmedRxiv · 2025-07-29 595. Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A RCTBiological Psychiatry · 2025-04-08 Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialUniversität Zürich, ZORA · 2025-03-31 Psilocybin has a narrow therapeutic window as an antidepressant treatmentProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-03-31 Alternative therapy for neurological and psychiatric disorders using psilocybinUnknown journal · 2024-12-31 Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.Frontiers in psychiatry · 2024-12-31 Amid magic and menace: psychiatrists’ attitudes to psilocybin therapyIrish Journal of Psychological Medicine · 2024-11-06 An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United StatesPsychedelics. · 2024-09-12 Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent EvidenceCurrent Psychopharmacologye · 2024-07-03 The influence of psilocybin on subconscious and conscious emotional learningiScience · 2024-05-18 Genetic regulation of l-tryptophan metabolism in Psilocybe mexicana supports psilocybin biosynthesisFungal Biology and Biotechnology · 2024-04-24 Author Correction: Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.Unknown journal · 2024-04-22 Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditationScientific Reports · 2024-03-25 Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometry.Unknown journal · 2024-02-29 A "Magic Mushroom" Multi-Product Sesquiterpene Synthase.Chembiochem: a European journal of chemical biology · 2023-11-01 Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.Unknown journal · 2023-01-29 Are psychedelics the answer to chronic pain: A review of current literature.Unknown journal · 2023-01-10 Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trialEClinicalMedicine · 2022-12-27 Psychedelics in the treatment of unipolar and bipolar depression.Unknown journal · 2022-07-04 The economics of psychedelic-assisted therapies: A research agenda.Frontiers in psychiatry · 2021-12-31 Psilocybin Induces Time-Dependent Changes in Global Functional ConnectivityBiological Psychiatry · 2020-01-12 Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in micebioRxiv · 2019-08-31 Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.European Neuropsychopharmacology · 2018-04-24 LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.Frontiers in Pharmacology · 2017-11-07 Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination taskEuropean Neuropsychopharmacology · 2016-09-30 Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.Proceedings of the National Academy of Sciences · 2016-04-17 The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.NeuroImage Clinical · 2015-08-21 Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.Psychopharmacology · 2015-07-31 P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI studyEuropean Neuropsychopharmacology · 2014-09-24 Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.Biological Psychiatry · 2014-04-25 Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.Cerebral Cortex · 2013-07-15 The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.Psychopharmacology · 2012-07-26 Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.Biological Psychiatry · 2012-05-09 Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.Unknown journal · 2011-10-25 Enhancement of Indole Alkaloids Produced by Psilocybe cubensis (Earle) Singer (Agaricomycetideae) in Controlled Harvesting Light ConditionsInternational journal of medicinal mushrooms · 2008-12-31 The pharmacology of psilocybin.Unknown journal · 2002-09-30 Effects of chlorpromazine and psilocin on pregnancy of c57bl/10 mice and their offspring at birth. Abstr.The Mouseion at the JAXlibrary (Jackson Laboratory) · 1966-12-31 The effects of psilocybin and lycergic acid on the extinction of avoidance behavior in rats.The Mouseion at the JAXlibrary (Jackson Laboratory) · 1960-12-31

Author directory